Domain finds unmet need in CF
Unmet need drives Domain's investment in Celtaxsys, its first in CF
Domain Associates has decided the best way to play the cystic fibrosis space is to find a molecule that can be combined with the ever-increasing number of cocktails emerging from Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). To do so, Domain led a